Annual Operating Profit
-$51.99 M
+$1.51 M+2.82%
December 31, 2023
Summary
- As of February 17, 2025, CUE annual operating income is -$51.99 million, with the most recent change of +$1.51 million (+2.82%) on December 31, 2023.
- During the last 3 years, CUE annual operating profit has fallen by -$6.95 million (-15.43%).
- CUE annual operating profit is now -2595.70% below its all-time high of -$1.93 million, reached on December 31, 2015.
Performance
CUE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$8.91 M
+$1.47 M+14.17%
September 30, 2024
Summary
- As of February 17, 2025, CUE quarterly operating income is -$8.91 million, with the most recent change of +$1.47 million (+14.17%) on September 30, 2024.
- Over the past year, CUE quarterly operating profit has stayed the same.
- CUE quarterly operating profit is now -340.27% below its all-time high of -$2.02 million, reached on September 30, 2016.
Performance
CUE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$45.64 M
+$2.51 M+5.21%
September 30, 2024
Summary
- As of February 17, 2025, CUE TTM operating income is -$45.64 million, with the most recent change of +$2.51 million (+5.21%) on September 30, 2024.
- Over the past year, CUE TTM operating profit has stayed the same.
- CUE TTM operating profit is now -2154.62% below its all-time high of -$2.02 million, reached on September 30, 2016.
Performance
CUE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
CUE Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.8% | 0.0% | 0.0% |
| 3 y3 years | -15.4% | 0.0% | 0.0% |
| 5 y5 years | -34.4% | 0.0% | 0.0% |
CUE Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.9% | +2.8% | -12.9% | +40.1% | -4.4% | +14.7% |
| 5 y | 5-year | -41.4% | +2.8% | -12.9% | +40.1% | -23.8% | +14.7% |
| alltime | all time | -2595.7% | +2.8% | -340.3% | +40.1% | -2154.6% | +14.7% |
Cue Biopharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.91 M(-14.2%) | -$45.64 M(-5.2%) |
| Jun 2024 | - | -$10.38 M(-18.0%) | -$48.15 M(-6.1%) |
| Mar 2024 | - | -$12.67 M(-7.4%) | -$51.28 M(-1.4%) |
| Dec 2023 | -$51.99 M(-2.8%) | -$13.68 M(+19.8%) | -$51.99 M(-2.3%) |
| Sep 2023 | - | -$11.42 M(-15.5%) | -$53.20 M(+0.7%) |
| Jun 2023 | - | -$13.52 M(+1.0%) | -$52.81 M(+0.3%) |
| Mar 2023 | - | -$13.38 M(-10.1%) | -$52.64 M(-1.6%) |
| Dec 2022 | -$53.50 M(+22.4%) | -$14.88 M(+34.9%) | -$53.50 M(+15.0%) |
| Sep 2022 | - | -$11.03 M(-17.4%) | -$46.51 M(-4.1%) |
| Jun 2022 | - | -$13.35 M(-6.3%) | -$48.50 M(+6.7%) |
| Mar 2022 | - | -$14.24 M(+80.4%) | -$45.45 M(+3.9%) |
| Dec 2021 | -$43.71 M(-3.0%) | -$7.89 M(-39.4%) | -$43.73 M(-6.6%) |
| Sep 2021 | - | -$13.02 M(+26.4%) | -$46.81 M(+6.6%) |
| Jun 2021 | - | -$10.30 M(-17.7%) | -$43.93 M(-1.4%) |
| Mar 2021 | - | -$12.52 M(+14.1%) | -$44.57 M(-1.1%) |
| Dec 2020 | -$45.04 M | -$10.97 M(+8.3%) | -$45.04 M(+4.5%) |
| Sep 2020 | - | -$10.13 M(-7.4%) | -$43.08 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$10.94 M(-15.8%) | -$40.05 M(+4.2%) |
| Mar 2020 | - | -$12.99 M(+44.1%) | -$38.43 M(+4.3%) |
| Dec 2019 | -$36.77 M(-5.0%) | -$9.02 M(+27.1%) | -$36.86 M(-5.0%) |
| Sep 2019 | - | -$7.09 M(-23.9%) | -$38.81 M(-12.7%) |
| Jun 2019 | - | -$9.32 M(-18.4%) | -$44.48 M(+4.3%) |
| Mar 2019 | - | -$11.43 M(+4.2%) | -$42.62 M(+10.1%) |
| Dec 2018 | -$38.70 M(+66.6%) | -$10.97 M(-14.0%) | -$38.72 M(+1.4%) |
| Sep 2018 | - | -$12.76 M(+70.8%) | -$38.19 M(+25.4%) |
| Jun 2018 | - | -$7.47 M(-0.7%) | -$30.46 M(+11.2%) |
| Mar 2018 | - | -$7.52 M(-27.9%) | -$27.41 M(+18.0%) |
| Dec 2017 | -$23.23 M(+203.4%) | -$10.44 M(+107.5%) | -$23.23 M(+48.6%) |
| Sep 2017 | - | -$5.03 M(+14.0%) | -$15.64 M(+23.8%) |
| Jun 2017 | - | -$4.41 M(+31.7%) | -$12.63 M(+53.7%) |
| Mar 2017 | - | -$3.35 M(+17.9%) | -$8.22 M(+68.8%) |
| Dec 2016 | -$7.66 M(+297.1%) | -$2.84 M(+40.4%) | -$4.87 M(+140.4%) |
| Sep 2016 | - | -$2.02 M | -$2.02 M |
| Dec 2015 | -$1.93 M | - | - |
FAQ
- What is Cue Biopharma annual operating income?
- What is the all time high annual operating profit for Cue Biopharma?
- What is Cue Biopharma annual operating profit year-on-year change?
- What is Cue Biopharma quarterly operating income?
- What is the all time high quarterly operating profit for Cue Biopharma?
- What is Cue Biopharma quarterly operating profit year-on-year change?
- What is Cue Biopharma TTM operating income?
- What is the all time high TTM operating profit for Cue Biopharma?
- What is Cue Biopharma TTM operating profit year-on-year change?
What is Cue Biopharma annual operating income?
The current annual operating profit of CUE is -$51.99 M
What is the all time high annual operating profit for Cue Biopharma?
Cue Biopharma all-time high annual operating income is -$1.93 M
What is Cue Biopharma annual operating profit year-on-year change?
Over the past year, CUE annual operating income has changed by +$1.51 M (+2.82%)
What is Cue Biopharma quarterly operating income?
The current quarterly operating profit of CUE is -$8.91 M
What is the all time high quarterly operating profit for Cue Biopharma?
Cue Biopharma all-time high quarterly operating income is -$2.02 M
What is Cue Biopharma quarterly operating profit year-on-year change?
Over the past year, CUE quarterly operating income has changed by $0.00 (0.00%)
What is Cue Biopharma TTM operating income?
The current TTM operating profit of CUE is -$45.64 M
What is the all time high TTM operating profit for Cue Biopharma?
Cue Biopharma all-time high TTM operating income is -$2.02 M
What is Cue Biopharma TTM operating profit year-on-year change?
Over the past year, CUE TTM operating income has changed by $0.00 (0.00%)